onkologie2012.de

Solide Tumoren - Gehirn und Nervensystem - Glioblastome -
Weiterführende Informationen

Leitlinien

Deutsche Ges. für Neuroonkologie: www.neuroonkologie.de → Leitlinien

ASTRO Evidence-Based Review of the role of radiosurgery for Malignant Glioma 2005. Int J Rad Oncol Phys 2005; 63: 44–7

Studien

Literatur

Brell et al: Prognostic significance of O6-methylguanine-DNA-methyltransferase determined by promotor hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 2005; 11: 5167–74
De Angelis et al: Chemotherapy for brain tumors – a new beginning. N Engl J Med 2005; 352: 1036–8
Hegi M et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997–1003
Reardon DA et al: Phase II study of imatinib mesylate plus Hydroxyurea in adults with recurrent glioblastoma multiforme. J Clin Oncol 2005; 23: 9359–68
Stummer et al: Fluorescence guided surgery with 5 aminolevulinic acid for resection of malignant glioma: A randomised controlled phase III trial. Lancet Oncology 2006; 7: 392–401
Stupp R et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005: 352: 987–96
Westphal M et al: Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir Wien 2006; 148: 269–75